Eurobio Scientific Société anonyme reported earnings results for the half year ended June 30, 2023. For the half year, the company reported revenue was EUR 59.4 million compared to EUR 84.3 million a year ago. Net income was EUR 2.2 million compared to EUR 19.2 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.76 EUR | -0.14% | +2.50% | -10.33% |
05-08 | Eurobio Scientific: agreement with Myriad Genetics | CF |
05-08 | Eurobio Scientific to Buy Gene Expression Test for Breast Cancer | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.33% | 162M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- ALERS Stock
- News Eurobio Scientific
- Eurobio Scientific Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023